125 related articles for article (PubMed ID: 31092454)
1. Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
Rades D; Hansen HC; Janssen S; Schild SE
Anticancer Res; 2019 May; 39(5):2569-2574. PubMed ID: 31092454
[TBL] [Abstract][Full Text] [Related]
2. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
[TBL] [Abstract][Full Text] [Related]
3. Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool.
Hansen HC; Janssen S; Schild SE; Rades D
Anticancer Res; 2019 Apr; 39(4):2091-2095. PubMed ID: 30952754
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
5. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
Rades D; Hansen HC; Schild SE; Janssen S
Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM.
Rades D; Sehmisch L; Hansen HC; Dziggel L; Janssen S; Schild SE
Anticancer Res; 2019 Mar; 39(3):1501-1505. PubMed ID: 30842188
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.
Heisterkamp C; Haatanen T; Schild SE; Rades D
Strahlenther Onkol; 2010 Feb; 186(2):70-75. PubMed ID: 20127223
[TBL] [Abstract][Full Text] [Related]
9. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study.
Koo T; Kim K; Park HJ; Han SW; Kim TY; Jeong SY; Park KJ; Chie EK
Sci Rep; 2020 Mar; 10(1):4340. PubMed ID: 32152433
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
Mix M; Elmarzouky R; O'Connor T; Plunkett R; Prasad D
J Neurosurg; 2016 Dec; 125(Suppl 1):26-30. PubMed ID: 27903186
[TBL] [Abstract][Full Text] [Related]
13. Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery.
Nagtegaal SHJ; Claes A; Suijkerbuijk KPM; Schramel FMNH; Snijders TJ; Verhoeff JJC
Radiother Oncol; 2019 Sep; 138():173-179. PubMed ID: 31302392
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer metastatic to the brain: analysis of prognostic factors and impact of KRAS mutations on presentation and outcome.
Nieder C; Hintz M; Grosu AL
Clin Transl Oncol; 2016 Jan; 18(1):88-92. PubMed ID: 26260912
[TBL] [Abstract][Full Text] [Related]
15. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
[TBL] [Abstract][Full Text] [Related]
16. Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
Gorovets D; Ayala-Peacock D; Tybor DJ; Rava P; Ebner D; Cielo D; Norén G; Wazer DE; Chan M; Hepel JT
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):246-253. PubMed ID: 28068233
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
18. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
Nieder C; Pawinski A; Molls M
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
[TBL] [Abstract][Full Text] [Related]
19. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):3111-3114. PubMed ID: 29715148
[TBL] [Abstract][Full Text] [Related]
20. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
